Go to deals
Healthcare | Private Equity

Vascotube GmbH has been acquired by Cirtec Medical Systems, LLC

Ordito GmbH, a private investment company, has sold Vascotube GmbH, a leading German manufacturer of high quality nitinol tubing, to 3i-backed Cirtec Medical Systems, LLC (Cirtec), a provider of design and contract manufacturing services for implantable and minimally invasive surgical devices. Financial details will remain confidential.

Founded in 2004, Vascotube processes nitinol tubing used in minimally invasive implantable medical devices. Nitinol’s properties of superelasticity and unique shape memory capabilities make it an ideal material for use in scaffold-like medical devices, such as peripheral and vascular stents, replacement heart valves, and embolic protection filters, that are compressed, inserted into the body intravenously and then expanded to pre-set shapes. Vascotube’s proprietary manufacturing process and focus on quality has made it a leading provider in its target markets and with its customers.

For over 25 years, Cirtec has been providing design, development, manufacturing and product transfer services for the medical device industry. With facilities in Los Gatos, California, Enfield, Connecticut, and Brooklyn Park, Minneapolis, the company specializes in outsourced solutions for active implantable devices in the areas of neuromodulation, drug delivery, cardiac rhythm management, ventricular assist, and minimally invasive devices.

Oaklins’ teams in Germany and the USA acted as the exclusive M&A advisor to the seller in this cross-border transaction. The team had previously closed deals in the industry and was able to use its broad experience and contacts gained during the prior projects. Oaklins' team in Switzerland supported the transaction in its early stages.

Parties

Talk to the deal team

Dr. Hans Bethge

Senior Advisor
Hamburg, Germany
Oaklins Germany

Dr. Roberto Tracia

Partner
Bern, Switzerland
Oaklins Switzerland

Related deals

Valmiermuižas Alus has been acquired by Cēsu Alus
Private Equity | Food & Beverage

Valmiermuižas Alus has been acquired by Cēsu Alus

Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more
Armira has signed an agreement to acquire a majority stake in Viabus
Private Equity | Consumer & Retail

Armira has signed an agreement to acquire a majority stake in Viabus

Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.

Learn more